There are exciting new data on 14 French patients who were treated during the first weeks of infection and who have successfully remained off of antiretroviral (ARV) therapy for an average of 7.5 years after interrupting prolonged treatment. These cases are exactly the kind we need…Read More
ACTION ALERT: Fight cuts to life-saving HIV services!
Right now millions of dollars in emergency funding for life-saving HIV/AIDS programs are threatened by massive budget slashes—but you can take action to stop those cuts. On World AIDS Day 2011, President Obama announced a $35 million emergency increase to the AIDS Drug Assistance Program (ADAP), as well…Read More
On Monday at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI), results from the ELECTRON study showed 100% of its participants who had hepatitis C but not HIV had a sustained virologic response (SVR) from taking two new drugs (sofosbuvir, ledipasvir) along with ribavirin for…Read More
CROI2013: Disappointing results of PrEP for women
A second clinical trial studying pre-exposure prophylaxis (PrEP) in women in Africa has found that the intervention was no more helpful than a placebo in preventing new HIV infections, but that once again this was highly likely due to the fact that very few women were…Read More
CROI2013: “Functional Cure” of baby, but questions remain
Researchers reported a case of a “functional cure” of a small child on Monday at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta. Dr. Deborah Persaud from Johns Hopkins University explained that a child, who appeared to be infected 30 hours after birth,…Read More
Project Inform to hold important think tank on the need for hepatitis C testing in the US
In September 2013, Project Inform will hold a think tank in Washington, DC entitled “Hepatitis C Testing: Addressing the Need in the Context of the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.” This meeting will bring together 30 experts to critically address…Read More
Recently, Anthem Blue Cross announced that it would require some of its plan subscribers to use a mail order pharmacy to obtain their medications. Specifically, those who depend on what Anthem has termed as “specialty drugs”, including HIV treatments. Such individuals will now have to obtain…Read More